Xaphe
Nucleic acid delivery technology and formulation services for life sciences researchers and drug developers
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-10
About Xaphe
XapHe develops delivery systems using its HAWC technology, which it says can be applied to nucleic acids of different sizes and types. Its services include transfection kits, custom nanoparticles, in-vitro delivery optimisation, and RNA design and synthesis.
Customers can purchase kits and bespoke research products or collaborate with XapHe on targeted delivery projects. XAPHE LTD was founded in 2024 and is based in Belfast, Northern Ireland.
Product: Nucleic acid delivery technology, transfection kits, custom nanoparticles, in-vitro delivery optimisation, and RNA design and synthesis services.
Jobs at Xaphe
Leadership
- Nicholas Dunne · CSO & Co-FounderSource: company website
- Helen McCarthy · CEO & Co-FounderSource: company website
More biotech & pharma companies
Xyme
AI-designed enzymes and programmable catalysts for industrial chemistry and energy applicationsYoung companyNew on EvolcYouseq
Molecular diagnostic qPCR and NGS tests, panels and reagents for laboratories, researchers and distributorsNew on EvolcZeta Analytical
Pharmaceutical testing and analytical method services for pharmaceutical organisations and life sciences clientsNew on Evolc4C Biomed
Pre-clinical immuno-oncology company finding immune targets and developing antibody drugs for cancer treatmentNew on EvolcAbacus Medicine Pharma Services
Commercialization and market-entry services for pharmaceutical innovators launching specialty medicines across EuropeNew on EvolcAbbaltis
Supplier of human disease-state plasma, serum and clinical samples to diagnostic manufacturers, biotech companies and laboratoriesNew on EvolcSalary transparent
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.